# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic pulmonary fibrosis

Familial pulmonary fibrosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 51-60 of 364 results.
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
Status: Completed
Last Changed: Feb 17, 2014
First Received: May 18, 2009
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): ACT-064992 (macitentan), Placebo
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Pulmonary Associates, P.A., Phoenix, Arizona, United States
Mayo Clinic - Arizona, Scottsdale, Arizona, United States
U.C. Davis University of California, Sacramento, California, United States
UCSD Pulmonary Critical Care, San Diego, California, United States
... and 49 other locations.
Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis
Status: Active, not recruiting
Last Changed: Dec 16, 2019
First Received: Dec 13, 2019
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Neuromuscular Electrical Stimulation, Core Stabilization Exercises
Locations: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF)
Status: Unknown status
Last Changed: Jun 07, 2018
First Received: Jun 07, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Virtual Autonomous Physiotherapist Agent (VAPA)
Locations: Jose Cerdan, Aarhus, Danmark, Denmark
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Status: Withdrawn
Last Changed: Sep 03, 2014
First Received: May 04, 2011
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Macitentan
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)
Status: Recruiting
Last Changed: Dec 11, 2019
First Received: Jun 19, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Usual Care of IPF, Telenursing, Telenursing and Remote Monitoring
Locations: Vanderbilt University Medical Center, Nashville, Tennessee, United States
Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging
Status: Terminated
Last Changed: Aug 12, 2019
First Received: Mar 03, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): GSK3008348, Placebo, [18F]-FBA-A20FMDV2
Locations: GSK Investigational Site, London, United Kingdom
GSK Investigational Site, London, United Kingdom
GSK Investigational Site, London, United Kingdom
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
Status: Terminated
Last Changed: Jun 04, 2020
First Received: Nov 16, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: Dept. of Respiratory Medicine, Dublin, Ireland
Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life
Status: Completed
Last Changed: Jan 30, 2020
First Received: Feb 05, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Home monitoring program
Locations: Erasmus MC, Rotterdam, Zuid-Holland, Netherlands
A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Status: Recruiting
Last Changed: Oct 22, 2020
First Received: Feb 06, 2019
Disease(s): Idiopathic Pulmonary Fibrosis (IPF)
Intervention(s): TD139, Placebo
Locations: SEC Clinical Research, Andalusia, Alabama, United States
Jasper Summit Research, LLC Pulmonary & Sleep Associates, Jasper, Alabama, United States
Palmtree Clinical Research Inc, Palm Springs, California, United States
Paradigm Research, Redding, California, United States
Yale University Scholl of Medicine, New Haven, Connecticut, United States
... and 83 other locations.
Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis
Status: Terminated
Last Changed: Jul 08, 2019
First Received: Mar 29, 2018
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Multi-Disciplinary Patient Centered Rehab and Education
Locations: Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States